| A case-control analysis of lymphocytic chromosome 9 aberrations in lung cancer. |
12432559 |
Int J Cancer |
| A myeloperoxidase polymorphism associated with reduced risk of lung cancer. |
12057865 |
Lung Cancer |
| A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. |
11691799 |
Cancer Res |
| A variant of the DNA repair gene XRCC3 and risk of squamous cell carcinoma of the head and neck: a case-control analysis. |
12115490 |
Int J Cancer |
| An intronic poly (AT) polymorphism of the DNA repair gene XPC and risk of squamous cell carcinoma of the head and neck: a case-control study. |
11309287 |
Cancer Res |
| Association between asbestos exposure, cigarette smoking, myeloperoxidase (MPO) genotypes, and lung cancer risk. |
12111688 |
Am J Ind Med |
| BPDE-induced lymphocytic 3p21.3 aberrations may predict head and neck carcinoma risk. |
12209748 |
Cancer |
| Chromosome instability in lymphocytes: a potential indicator of predisposition to oral premalignant lesions. |
12019158 |
Cancer Res |
| Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: a case-control study. |
11470749 |
Carcinogenesis |
| Diminished expression of S100A2, a putative tumor suppressor, at early stage of human lung carcinogenesis. |
11691825 |
Cancer Res |
| Expression of nucleotide excision repair genes and the risk for squamous cell carcinoma of the head and neck. |
11900225 |
Cancer |
| Gamma-radiation-induced G2 delay, apoptosis, and p53 response as potential susceptibility markers for lung cancer. |
11691798 |
Cancer Res |
| Haplotypes of two variants in p16 (CDKN2/MTS-1/INK4a) exon 3 and risk of squamous cell carcinoma of the head and neck: a case-control study. |
12101111 |
Cancer Epidemiol Biomarkers Prev |
| Lung carcinoma patients with a family history of cancer and lymphocyte primary chromosome 9 aberrations. |
9118034 |
Cancer |
| Microsomal epoxide hydrolase polymorphisms and lung cancer risk in non-Hispanic whites. |
11813302 |
Mol Carcinog |
| Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. |
11245433 |
Cancer Res |
| Modulation of repair of ultraviolet damage in the host-cell reactivation assay by polymorphic XPC and XPD/ERCC2 genotypes. |
11872635 |
Carcinogenesis |
| P53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck: a case-control study. |
12065086 |
Cancer Lett |
| p53 Genotypes and Haplotypes Associated With Lung Cancer Susceptibility and Ethnicity. |
11983757 |
J Natl Cancer Inst |
| Plasma concentrations of insulin-like growth factors among healthy adult men and postmenopausal women: associations with body composition, lifestyle, and reproductive factors. |
12163330 |
Cancer Epidemiol Biomarkers Prev |
| Plasma levels of insulin-like growth factor-1 and binding protein-3, and their association with bladder cancer risk. |
12544349 |
J Urol |
| Polymorphic hCHK2/hCds1 codon 84 allele and risk of squamous cell carcinoma of the head and neck--a case-control analysis. |
11751432 |
Carcinogenesis |
| Polymorphism of DNA ligase I and risk of lung cancer--a case-control analysis. |
12009232 |
Lung Cancer |
| Polymorphisms of methylene-tetrahydrofolate reductase and risk of lung cancer: a case-control study. |
11319182 |
Cancer Epidemiol Biomarkers Prev |
| Polymorphisms, mutations, and amplification of the EGFR gene in non-small cell lung cancers. |
17455987 |
PLoS Med |
| Sensitivity to benzo(a)pyrene diol-epoxide associated with risk of breast cancer in young women and modulation by glutathione S-transferase polymorphisms: a case-control study. |
11731429 |
Cancer Res |
| Sulfotransferase (SULT) 1A1 polymorphism as a predisposition factor for lung cancer: a case-control analysis. |
11804685 |
Lung Cancer |
| The association of microsomal epoxide hydrolase polymorphisms and lung cancer risk in African-Americans and Mexican-Americans. |
11375900 |
Carcinogenesis |
| XPD/ERCC2 EXON 8 Polymorphisms: rarity and lack of significance in risk of squamous cell carcinoma of the head and neck. |
12110342 |
Oral Oncol |
